What is Cavitation Technologies Inc's earnings per share (EPS)?

Cavitation Technologies Inc (CVAT) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cavitation Technologies Inc Financials

CVAT

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE June

This page shows Cavitation Technologies Inc (CVAT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CVAT FY2025 2026-05-20

Overhead, not production cost, dominates results as high-margin revenue arrives too unevenly to support the company.

FY2025's cleaner balance sheet did not come from healthier operations: cash ended at $249K even though operating cash flow was -$806K. The bridge was an investing cash inflow of $880K, and the same mismatch appears in earnings, where the -$113K net loss looks milder than core operations actually were.

The unit economics look far better than the bottom line suggests. Gross margin stayed above 70.0% in every valid year, but FY2025 SG&A of $1.1M sat far above gross profit of $165K, so the business is being constrained by overhead and uneven sales activity rather than production cost.

The brief FY2024 profit appears episodic, not a settled new level. Revenue fell to $203K in FY2025 while the liquidity picture improved to a 3.7x current ratio; equity also turned positive at $69K, showing short-term solvency improved even as the sales engine weakened.

Financial Health Signals

Financial health score pending refresh

We are recalculating Cavitation Technologies Inc's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Altman Z-Score Distress

-112.16

Cavitation Technologies Inc scores -112.16, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($9.3M) relative to total liabilities ($228K). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

2/9

Cavitation Technologies Inc passes 2 of 9 financial strength tests. No profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality

7.13x

For every $1 of reported earnings, Cavitation Technologies Inc generates $7.13 in operating cash flow (-$806K OCF vs -$113K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-164.5x

Cavitation Technologies Inc earns $-164.5 in operating income for every $1 of interest expense (-$987K vs $6K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$203K

YoY-85.1%

5Y CAGR-34.3%

10Y CAGR-8.4%

Cavitation Technologies Inc generated $203K in revenue in fiscal year 2025. This represents a decrease of 85.1% from the prior year.

EBITDA

-$987K

YoY-324.8%

Cavitation Technologies Inc's EBITDA was -$987K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 324.8% from the prior year.

Net Income

-$113K

YoY-125.7%

Cavitation Technologies Inc reported -$113K in net income in fiscal year 2025. This represents a decrease of 125.7% from the prior year.

EPS (Diluted)

$0.00

Cavitation Technologies Inc earned $0.00 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$249K

YoY+39.1%

5Y CAGR-20.0%

10Y CAGR-16.3%

Cavitation Technologies Inc held $249K in cash against $150K in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

289M

YoY+1.7%

5Y CAGR+8.0%

10Y CAGR+4.6%

Cavitation Technologies Inc had 289M shares outstanding in fiscal year 2025. This represents an increase of 1.7% from the prior year.

Margins & Returns

Gross Margin

81.3%

YoY-7.3pp

5Y CAGR-16.3pp

10Y CAGR-3.7pp

Cavitation Technologies Inc's gross margin was 81.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 7.3 percentage points from the prior year.

Operating Margin

-486.2%

YoY-518.3pp

5Y CAGR-494.4pp

Cavitation Technologies Inc's operating margin was -486.2% in fiscal year 2025, reflecting core business profitability. This is down 518.3 percentage points from the prior year.

Net Margin

-55.7%

YoY-87.9pp

5Y CAGR-63.4pp

10Y CAGR+226.2pp

Cavitation Technologies Inc's net profit margin was -55.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 87.9 percentage points from the prior year.

Return on Equity

-163.8%

Cavitation Technologies Inc's ROE was -163.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending

$95K

YoY+55.7%

5Y CAGR+39.5%

10Y CAGR+15.6%

Cavitation Technologies Inc invested $95K in research and development in fiscal year 2025. This represents an increase of 55.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

CVAT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$203K-85.1%	$1.4M+214.8%	$433K-73.3%	$1.6M+190.1%	$558K-66.4%	$1.7M
Cost of Revenue	$38K-75.6%	$156K+28.9%	$121K+195.1%	$41K+105.0%	$20K-50.0%	$40K
Gross Profit	$165K-86.3%	$1.2M+286.9%	$312K-80.2%	$1.6M+193.3%	$538K-66.9%	$1.6M
R&D Expenses	$95K+55.7%	$61K+1933.3%	$3K-82.4%	$17K-19.0%	$21K+16.7%	$18K
SG&A Expenses	$1.1M+49.3%	$708K-40.8%	$1.2M-30.8%	$1.7M+36.7%	$1.3M-14.0%	$1.5M
Operating Income	-$987K-325.3%	$438K+149.4%	-$886K-196.3%	-$299K+60.0%	-$747K-649.3%	$136K
Interest Expense	$6K+700.0%	-$1K-116.7%	$6K+20.0%	$5K-16.7%	$6K	$0
Income Tax	N/A	N/A	$0	$0	$0	$0
Net Income	-$113K-125.7%	$439K+121.5%	-$2.0M-229.6%	-$619K+4.6%	-$649K-607.0%	$128K
EPS (Diluted)	$0.00	$0.00+100.0%	$-0.01	$0.00	$0.00	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$3K	$0-100.0%	$3K	N/A	$122K+60.5%	$76K	$0	N/A
Cost of Revenue	$0	$0	N/A	N/A	$25K+92.3%	$13K	N/A	N/A
Gross Profit	$3K	$0	N/A	N/A	$97K+54.0%	$63K	N/A	N/A
R&D Expenses	N/A	$4K-42.9%	$7K	N/A	$42K+162.5%	$16K+100.0%	$8K	N/A
SG&A Expenses	$234K	N/A	$245K	N/A	$283K-18.2%	$346K+58.7%	$218K	N/A
Operating Income	-$231K	N/A	-$249K	N/A	-$228K+23.7%	-$299K-32.3%	-$226K	N/A
Interest Expense	$3K+50.0%	$2K-77.8%	$9K	N/A	$2K0.0%	$2K+100.0%	$1K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$219K	N/A	-$258K	N/A	-$230K-139.7%	$579K+355.1%	-$227K	N/A
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A

CVAT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$297K+19.8%	$248K+73.4%	$143K-92.4%	$1.9M+2.2%	$1.8M+40.4%	$1.3M
Current Assets	$286K+46.7%	$195K+983.3%	$18K-96.6%	$528K-62.1%	$1.4M+53.2%	$910K
Cash & Equivalents	$249K+39.1%	$179K+894.4%	$18K-95.9%	$441K-67.6%	$1.4M+79.6%	$759K
Inventory	N/A	$0	$0-100.0%	$48K+92.0%	$25K-46.8%	$47K
Accounts Receivable	$10K	$0	$0-100.0%	$1K-83.3%	$6K-94.2%	$104K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$228K-68.7%	$728K-31.5%	$1.1M+27.2%	$835K-62.8%	$2.2M+25.0%	$1.8M
Current Liabilities	$78K-87.0%	$598K-30.8%	$864K+54.8%	$558K-68.9%	$1.8M+25.3%	$1.4M
Long-Term Debt	$150K+15.4%	$130K-10.3%	$145K-3.3%	$150K-40.9%	$254K	N/A
Total Equity	$69K+114.4%	-$480K+47.8%	-$919K-188.7%	$1.0M+352.1%	-$411K+16.1%	-$490K
Retained Earnings	-$27.0M-0.4%	-$26.8M+1.6%	-$27.3M-8.1%	-$25.2M-2.5%	-$24.6M-2.7%	-$24.0M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$66K+20.0%	$55K-8.3%	$60K-79.8%	$297K-48.4%	$576K-19.8%	$718K+832.5%	$77K-69.0%	$248K
Current Assets	$55K+25.0%	$44K-10.2%	$49K-82.9%	$286K-49.4%	$565K-19.4%	$701K+1569.0%	$42K-78.5%	$195K
Cash & Equivalents	$45K+45.2%	$31K+3.3%	$30K-88.0%	$249K-42.4%	$432K-36.6%	$681K+33950.0%	$2K-98.9%	$179K
Inventory	N/A	N/A	N/A	N/A	N/A	$11K	N/A	$0
Accounts Receivable	$3K	$0-100.0%	$5K-50.0%	$10K-91.8%	$122K	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$533K+75.9%	$303K+21.7%	$249K+9.2%	$228K-17.7%	$277K-62.6%	$741K-5.5%	$784K+7.7%	$728K
Current Liabilities	$383K+150.3%	$153K+54.5%	$99K+26.9%	$78K-48.0%	$150K-75.5%	$613K-6.6%	$656K+9.7%	$598K
Long-Term Debt	$150K0.0%	$150K0.0%	$150K0.0%	$150K+18.1%	$127K-0.8%	$128K0.0%	$128K-1.5%	$130K
Total Equity	-$467K-88.3%	-$248K-31.2%	-$189K-373.9%	$69K-76.9%	$299K+1400.0%	-$23K+96.7%	-$707K-47.3%	-$480K
Retained Earnings	-$27.9M-0.8%	-$27.7M-1.7%	-$27.2M-1.0%	-$27.0M-0.9%	-$26.7M-0.9%	-$26.5M+2.1%	-$27.1M-0.8%	-$26.8M

CVAT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$806K-568.6%	$172K+140.7%	-$423K+12.6%	-$484K-93.6%	-$250K-546.4%	$56K
Capital Expenditures	N/A	N/A	N/A	N/A	$128K+156.0%	$50K
Free Cash Flow	N/A	N/A	N/A	N/A	-$378K-6400.0%	$6K
Investing Cash Flow	$880K	$0	$0+100.0%	-$1.2M-855.5%	-$128K-156.0%	-$50K
Financing Cash Flow	-$4K+63.6%	-$11K	$0-100.0%	$785K-20.1%	$982K+844.2%	$104K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	-$126K+30.8%	-$182K+16.9%	-$219K-20.3%	-$182K+26.6%	-$248K-23.4%	-$201K-14.9%	-$175K-2600.0%	$7K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	N/A	N/A	$0	$0	N/A	N/A	$0
Financing Cash Flow	$140K-23.5%	$183K	$0+100.0%	-$1K0.0%	-$1K	$0+100.0%	-$2K+81.8%	-$11K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CVAT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	81.3%-7.3pp	88.5%+16.5pp	72.1%-25.4pp	97.5%+1.1pp	96.4%-1.2pp	97.6%
Operating Margin	-486.2%-518.3pp	32.1%+236.7pp	-204.6%-186.1pp	-18.5%+115.4pp	-133.9%-142.1pp	8.2%
Net Margin	-55.7%-87.9pp	32.2%+503.3pp	-471.1%-432.9pp	-38.2%+78.1pp	-116.3%-124.0pp	7.7%
Return on Equity	-163.8%	N/A	N/A	-59.8%	N/A	N/A
Return on Assets	-38.0%-215.1pp	177.0%+1603.6pp	-1426.6%-1393.5pp	-33.1%+2.4pp	-35.4%-45.3pp	9.8%
Current Ratio	3.67+3.3	0.33+0.3	0.02-0.9	0.95+0.2	0.78+0.1	0.64
Debt-to-Equity	2.17+2.4	-0.27-0.1	-0.16-0.3	0.14+0.8	-0.62+3.0	-3.66
FCF Margin	N/A	N/A	N/A	N/A	-67.7%-68.1pp	0.4%

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	100.0%	N/A	N/A	N/A	79.5%-3.4pp	82.9%	N/A	N/A
Operating Margin	-7700.0%	N/A	-8300.0%	N/A	-186.9%+206.5pp	-393.4%	N/A	N/A
Net Margin	-7300.0%	N/A	-8600.0%	N/A	-188.5%-950.4pp	761.8%	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	-76.9%	N/A	N/A	N/A
Return on Assets	-331.8%	N/A	-430.0%	N/A	-39.9%-120.6pp	80.6%+375.5pp	-294.8%	N/A
Current Ratio	0.14-0.1	0.29-0.2	0.49-3.2	3.67-0.1	3.77+2.6	1.14+1.1	0.06-0.3	0.33
Debt-to-Equity	-0.32+0.3	-0.60+0.2	-0.79-3.0	2.17+1.7	0.42+6.0	-5.57-5.4	-0.18+0.1	-0.27
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Titan Logic Corp TPCFF

$9.4M

Cleantek Industries Inc GLKFF

$18.4M

American Power APGI

$10.1M

Veloryx Ltd AQUEF

$14.6M

Newhydrogen Inc NEWH

$14.4M

Frequently Asked Questions

What is Cavitation Technologies Inc's annual revenue?

Cavitation Technologies Inc (CVAT) reported $203K in total revenue for fiscal year 2025. This represents a -85.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cavitation Technologies Inc's revenue growing?

Cavitation Technologies Inc (CVAT) revenue declined by 85.1% year-over-year, from $1.4M to $203K in fiscal year 2025.

Is Cavitation Technologies Inc profitable?

No, Cavitation Technologies Inc (CVAT) reported a net income of -$113K in fiscal year 2025, with a net profit margin of -55.7%.

What is Cavitation Technologies Inc's EBITDA?

Cavitation Technologies Inc (CVAT) had EBITDA of -$987K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cavitation Technologies Inc have?

As of fiscal year 2025, Cavitation Technologies Inc (CVAT) had $249K in cash and equivalents against $150K in long-term debt.

What is Cavitation Technologies Inc's gross margin?

Cavitation Technologies Inc (CVAT) had a gross margin of 81.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cavitation Technologies Inc's operating margin?

Cavitation Technologies Inc (CVAT) had an operating margin of -486.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cavitation Technologies Inc's net profit margin?

Cavitation Technologies Inc (CVAT) had a net profit margin of -55.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Cavitation Technologies Inc's return on equity (ROE)?

Cavitation Technologies Inc (CVAT) has a return on equity of -163.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cavitation Technologies Inc's operating cash flow?

Cavitation Technologies Inc (CVAT) generated -$806K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Cavitation Technologies Inc's total assets?

Cavitation Technologies Inc (CVAT) had $297K in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Cavitation Technologies Inc spend on research and development?

Cavitation Technologies Inc (CVAT) invested $95K in research and development during fiscal year 2025.

How many shares does Cavitation Technologies Inc have outstanding?

Cavitation Technologies Inc (CVAT) had 289M shares outstanding as of fiscal year 2025.

What is Cavitation Technologies Inc's current ratio?

Cavitation Technologies Inc (CVAT) had a current ratio of 3.67 as of fiscal year 2025, which is generally considered healthy.

What is Cavitation Technologies Inc's debt-to-equity ratio?

Cavitation Technologies Inc (CVAT) had a debt-to-equity ratio of 2.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cavitation Technologies Inc's return on assets (ROA)?

Cavitation Technologies Inc (CVAT) had a return on assets of -38.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Cavitation Technologies Inc's cash runway?

Based on fiscal year 2025 data, Cavitation Technologies Inc (CVAT) had $249K in cash against an annual operating cash burn of $806K. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Cavitation Technologies Inc's Altman Z-Score?

Cavitation Technologies Inc (CVAT) has an Altman Z-Score of -112.16, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Cavitation Technologies Inc's Piotroski F-Score?

Cavitation Technologies Inc (CVAT) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cavitation Technologies Inc's earnings high quality?

Cavitation Technologies Inc (CVAT) has an earnings quality ratio of 7.13x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cavitation Technologies Inc cover its interest payments?

Cavitation Technologies Inc (CVAT) has an interest coverage ratio of -164.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.